Raleigh Capital Management’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.42M | Sell |
12,820
-6,315
| -33% | -$700K | 0.6% | 54 |
|
|
2025
Q1 | $2.14M | Sell |
19,135
-11,048
| -37% | -$1.24M | 0.97% | 20 |
|
|
2024
Q4 | $2.79M | Sell |
30,183
-3,014
| -9% | -$278K | 1.07% | 13 |
|
|
2024
Q3 | $2.78M | Buy |
33,197
+7,801
| +31% | +$654K | 1.07% | 15 |
|
|
2024
Q2 | $1.74M | Buy |
25,396
+1,248
| +5% | +$85.6K | 0.74% | 33 |
|
|
2024
Q1 | $1.77M | Buy |
24,148
+4,576
| +23% | +$335K | 0.76% | 38 |
|
|
2023
Q4 | $1.59M | Sell |
19,572
-396
| -2% | -$32.1K | 0.74% | 40 |
|
|
2023
Q3 | $1.5M | Buy |
19,968
+2,148
| +12% | +$161K | 0.76% | 43 |
|
|
2023
Q2 | $1.37M | Sell |
17,820
-9,528
| -35% | -$734K | 0.69% | 49 |
|
|
2023
Q1 | $2.27M | Sell |
27,348
-19,149
| -41% | -$1.59M | 1.12% | 20 |
|
|
2022
Q4 | $3.99M | Sell |
46,497
-3,924
| -8% | -$337K | 2.08% | 3 |
|
|
2022
Q3 | $3.11M | Buy |
50,421
+10,140
| +25% | +$626K | 1.82% | 4 |
|
|
2022
Q2 | $2.49M | Buy |
40,281
+13,013
| +48% | +$804K | 1.42% | 12 |
|
|
2022
Q1 | $1.62M | Buy |
27,268
+27,194
| +36,749% | +$1.62M | 0.88% | 28 |
|
|
2021
Q4 | $5K | Buy |
+74
| New | +$5K | 0.01% | 234 |
|